Works about VASCULITIS
Results: 5000
Comparison of [<sup>18</sup>F]fluorodeoxyglucose and [<sup>68</sup>Ga]Gallium DOTA-TATE in patients with active giant cell arteritis.
- Published in:
- EJNMMI Reports, 2025, v. 9, n. 1, p. 1, doi. 10.1186/s41824-025-00242-y
- By:
- Publication type:
- Article
Factors associated with renal involvement in adult immunoglobulin a vasculitis: what is it?
- Published in:
- Postgraduate Medicine, 2025, v. 137, n. 2, p. 174, doi. 10.1080/00325481.2025.2454216
- By:
- Publication type:
- Article
Cryoglobulinaemic vasculitis and glomerulonephritis associated with schistosomiasis: a case study.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Diagnosing rashes, part 7: Purpuric rashes.
- Published in:
- Practice Nursing, 2014, v. 25, n. 1, p. 23, doi. 10.12968/pnur.2014.25.1.23
- By:
- Publication type:
- Article
Early diagnosis of rheumatoid arthritis.
- Published in:
- Practice Nursing, 2013, v. 24, n. 3, p. 146, doi. 10.12968/pnur.2013.24.3.146
- By:
- Publication type:
- Article
Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Unusual synchronous presentation of maxillary sinus fibrosarcoma and gemistocytic astrocytoma with a complication called leukocytoclastic vasculitis: a case report.
- Published in:
- Journal of Oral Implantology, 2010, v. 36, n. 2, p. 159
- By:
- Publication type:
- Article
Granulocyte and Monocyte Adsorption Apheresis for Cutaneous Allergic Vasculitis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2006, v. 10, n. 3, p. 287, doi. 10.1111/j.1744-9987.2006.00335.x
- By:
- Publication type:
- Article
Treatment With Cytapheresis for Antineutrophil Cytoplasmic Antibody-associated Renal Vasculitis and Its Effect on Anti-inflammatory Factors.
- Published in:
- Therapeutic Apheresis & Dialysis, 2005, v. 9, n. 4, p. 297, doi. 10.1111/j.1744-9987.2005.00285.x
- By:
- Publication type:
- Article
Indications of Plasma Exchanges for Systemic Vasculitides.
- Published in:
- Therapeutic Apheresis & Dialysis, 2003, v. 7, n. 2, p. 155, doi. 10.1046/j.1526-0968.2003.00036.x
- By:
- Publication type:
- Article
KUMELIŲ GIMDOS GLEIVINĖS ANGIOPATIJOS.
- Published in:
- Veterinarija ir Zootechnika, 2008, v. 42, n. 64, p. 58
- By:
- Publication type:
- Article
Disease activity assessment in childhood Vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 32
- By:
- Publication type:
- Article
Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAs) therapeutic trials.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 29
- By:
- Publication type:
- Article
von Willebrand factor antigen -- a possible biomarker of disease activity in childhood central nervous system vasculitis?
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 13
- By:
- Publication type:
- Article
Intrarenal corpuscular multinucleated giant cells in ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2023, v. 27, n. 2, p. 197, doi. 10.1007/s10157-022-02279-w
- By:
- Publication type:
- Article
The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 11, p. 1092, doi. 10.1007/s10157-022-02253-6
- By:
- Publication type:
- Article
Nephritis-associated plasmin receptor (NAPlr) in streptococcal infection associated cutaneous IgA vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 11, p. 1146, doi. 10.1007/s10157-022-02251-8
- By:
- Publication type:
- Article
Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 1, p. 37, doi. 10.1007/s10157-020-01968-8
- By:
- Publication type:
- Article
Vasculitis with nonpalpable purpura resembling purpura fulminans.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 2, p. 190, doi. 10.1007/s10157-019-01824-4
- By:
- Publication type:
- Article
Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 2, p. 136, doi. 10.1007/s10157-019-01799-2
- By:
- Publication type:
- Article
Low serum complement 3 level is associated with severe ANCA-associated vasculitis at diagnosis.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 2, p. 223, doi. 10.1007/s10157-018-1634-7
- By:
- Publication type:
- Article
Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 5, p. 712, doi. 10.1007/s10157-015-1200-5
- By:
- Publication type:
- Article
The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 5, p. 851, doi. 10.1007/s10157-014-1073-z
- By:
- Publication type:
- Article
Serum soluble levels of the transmembrane activator and calcium-modulator and cyclophilin-ligand interactor in MPO-ANCA-associated renal vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 4, p. 759, doi. 10.1007/s10157-015-1080-8
- By:
- Publication type:
- Article
History of Kawasaki disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 301, doi. 10.1007/s10157-013-0877-6
- By:
- Publication type:
- Article
The Asia Pacific Meeting for Vasculitis and ANCA Workshop 2012: surgical treatment for Takayasu's arteritis.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 296, doi. 10.1007/s10157-013-0894-5
- By:
- Publication type:
- Article
Skin involvement in ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 676, doi. 10.1007/s10157-012-0736-x
- By:
- Publication type:
- Article
Erratum to: Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 705, doi. 10.1007/s10157-012-0702-7
- By:
- Publication type:
- Article
Limited pulmonary MPA, a new MPA entity? A rheumatologist's perspective.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 672, doi. 10.1007/s10157-012-0733-0
- By:
- Publication type:
- Article
Epidemiology of vasculitides: differences between Japan, Europe and North America.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 611, doi. 10.1007/s10157-013-0813-9
- By:
- Publication type:
- Article
Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 659, doi. 10.1007/s10157-012-0755-7
- By:
- Publication type:
- Article
Clinical trial for Japanese patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis: the JMAAV study.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 700, doi. 10.1007/s10157-013-0821-9
- By:
- Publication type:
- Article
ANCA-associated vasculitis: report from Korea.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 708, doi. 10.1007/s10157-012-0754-8
- By:
- Publication type:
- Article
Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 622, doi. 10.1007/s10157-013-0860-2
- By:
- Publication type:
- Article
Possible implication of disordered neutrophil extracellular traps in the pathogenesis of MPO-ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 631, doi. 10.1007/s10157-012-0738-8
- By:
- Publication type:
- Article
Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 646, doi. 10.1007/s10157-012-0740-1
- By:
- Publication type:
- Article
Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 603, doi. 10.1007/s10157-013-0869-6
- By:
- Publication type:
- Article
Pathology of ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 652, doi. 10.1007/s10157-012-0701-8
- By:
- Publication type:
- Article
Complement in antineutrophil cytoplasmic antibody-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 642, doi. 10.1007/s10157-012-0700-9
- By:
- Publication type:
- Article
Clinicopathological features of neuropathy in anti-neutrophil cytoplasmic antibody-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 683, doi. 10.1007/s10157-012-0767-3
- By:
- Publication type:
- Article
New-generation therapy for ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 694, doi. 10.1007/s10157-013-0855-z
- By:
- Publication type:
- Article
Kawasaki disease: basic and pathological findings.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 690, doi. 10.1007/s10157-012-0734-z
- By:
- Publication type:
- Article
Clinical studies of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 697, doi. 10.1007/s10157-013-0845-1
- By:
- Publication type:
- Article
Vasculitis in New Zealand.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 712, doi. 10.1007/s10157-012-0703-6
- By:
- Publication type:
- Article
The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 634, doi. 10.1007/s10157-013-0787-7
- By:
- Publication type:
- Article
Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 638, doi. 10.1007/s10157-013-0861-1
- By:
- Publication type:
- Article
Vasculitis: report from Mexico.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 715, doi. 10.1007/s10157-012-0748-6
- By:
- Publication type:
- Article
ANCA testing: the current stage and perspectives.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 615, doi. 10.1007/s10157-012-0735-y
- By:
- Publication type:
- Article
Genetics of ANCA-associated vasculitis in Japan: a role for HLA- DRB1*09:01 haplotype.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 5, p. 628, doi. 10.1007/s10157-012-0691-6
- By:
- Publication type:
- Article